Strategic Advantage Leverage miDiagnostics’ miniaturized, lab-quality testing platform with built-in connectivity to position as a rapid point-of-care solution for hospitals, clinics, and remote care settings, enabling faster decision-making and improved patient throughput.

High Growth Potential Target health systems and diagnostic networks with expanding biomarker panels and infectious disease monitoring capabilities, aligning with their scalable chip-and-reader architecture to broaden test menus and deepen usage across departments.

Affiliations & Credibility Highlight collaborations and endorsements from imec and Johns Hopkins, plus recent industry awards, to build credibility with procurement teams and accelerate pilots, contract discussions, and co-development opportunities.

Global Market Position Capitalize on Europe-focused recognition and leadership awards to approach European healthcare providers and government programs seeking innovative, cost-effective diagnostic technologies with international potential.

Funding & Growth Signals Present the company’s substantial funding ($72M) and lean revenue profile as a signaling factor for customers seeking vendor with strong backing, R&D continuity, and long-term roadmap, while tailoring pilots to showcase ROI and reliability.